Mauno Vihinen¹, Pekka T. Mattsson^2,3 and C. I. Edvard Smith²

¹Department of Biosciences, Division of Biochemistry, P. O. Box 56, FIN-00014 University of Helsinki, Finland

²Center for BioTechnology, Department of Bioscience at Novum, Karolinska Institute, S-141 57 Huddinge and Department of Immunology, Microbiology, Pathology and Infectious Diseases (IMPI), Karolinska Institute, Huddinge University Hospital, S-141 86 Huddinge, Sweden

³Department of Biochemistry and Food Chemistry, University of Turku, Vatselankatu 2, Arcanum, FIN-20014 Turku, Finland

Received 11/24/96; Accepted 12/16/96; On-line 01/01/97

8. REFERENCES

1. P. Sideras, & C. I. E. Smith: Molecular and cellular aspects of X-linked agammaglobulinemia. Adv Immunol 59, 135-223 (1995).

2. F. S. Rosen, M. D. Cooper & R. J. P. Wegdwood: The primary immunodeficiencies (1). New Engl J Med 311, 235242 (1984).

3. O. C. Bruton: Agammaglobulinemia. Pediatrics 9, 722-727 (1952).

4. H. M. Lederman & J. A. Winkelstein: X-linked agammaglobulinemia: an analysis of 96 patients. Medicine (Baltimore) 64, 145-56 (1985).

5. E. E. McKinney Jr, S. L. Katz & C. M Wilfert: Chronic enteroviral meningoencephalitis in agammaglobulinemic patients. Rev Infect Dis 9, 334-56 (1987).

6. D. Vetrie, I. Vorechovský, P. Sideras, J. Holland, A. Davies, F. Flinter, L. Hammarström, C. Kinnon, R. Levinsky, M. Bobrow, C. I. E. Smith & D. R. Bentley: The gene involved in X-linked agammaglobulinemia is a member of the src family of the protein-tyrosine kinases. Nature 361, 226-33 (1993).

7. S. Tsukada, D. C. Saffran, D. J. Rawlings, O. Parolini, R. C. Allen, I. Klisak, R. S. Sparkes, H. Kubagawa, T. Mohandas, S. Quan, J. W. Belmont, M. D. Cooper, M. E. Conley & O. N. Witte: Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia. Cell 72, 279-90 (1993).

8. C. I. E. Smith & L. D. Notarangelo: Molecular basis for X-linked immunodeficiencies. Adv Genet 35, 57-115 (1997).

9. H. D. Ochs & C. I. E. Smith: X-linked agammaglobulinemia. A clinical and molecular analysis. Medicine (in press).

10. S. Guioli, B. Arveiler, B. Bardoni, L. D. Notarangelo, P. Panina, M. Duse, A. Ugazio, I. Oberle, G. de Saint Basile. J. L. Mandel & G Camerino: Close linkage of probe p212 (DXS178) to X-linked agammaglobulinemia. Hum Genet 84, 19-21 (1989).

11. S.-P. Kwan, J. Terwilliger, R. Parmley, G. Raghu, L. A. Sandkuyl, J. Ott, H. Ochs, R. Wedgwood & F. Rosen: Identification of a closely linked DNA marker, DXS178, to further refine the X-linked agammaglobulinemia locus. Genomics 6, 238-42 (1990).

12. L. Tamagnone, I. Lahtinen, T. Mustonen, K. Virtaneva, F. Francis, F. Muscatelli, R. Alitalo, C. I. E. Smith, C. Larsson & K. Alitalo: BMX, a novel nonreceptor tyrosine kinase gene of the BTK/ITK/TEC/TXK family located in chromosome Xp22.2. Oncogene 9, 3683-8 (1994).

13. R. N. Haire, Y. Ohta, J. E. Lewis, S. M. Fu, P. Kroisel & G. W. Litman: TXK, a novel human tyrosine kinase expressed in T cells shares sequence identity with Tec family kinases and maps to 4p12. Hum Mol Genet 3, 897-901 (1994).

14. Q. Hu, D. Davidson, P. L. Schwartzberg, F. Macchiarini, M. J. Lenardo, J. A. Bluestone & L. A. Matis: Identification of Rlk, a novel protein tyrosine kinase with predominant expression in the T cell lineage. J Biol Chem 270, 1928-34 (1995).

15. H. Mano, F. Ishikawa, J. Nishida, H. Hiraio & F. Takaku: A novel protein-tyrosine kinase, tec, is preferentially expressed in liver. Oncogene 5, 1781-6 (1990).

16. I. Scher: The CBA/N mouse strain: an experimental model illustrating the influence of the X-chromosome on immunity. Adv Immunol 33, 1-71 (1982).

17. L. S. Wicker & I. Scher: X-linked immune deficiency (xid) of CBA/N mice. Curr Top Microbiol Immunol 124, 87-101 (1986).

18. N. F. Go, B. E. Castle, R. Barrett, R. Kastelein, W. Dang, T. R. Mosmann, K. W. Moore & M. Howard: Interleukin 10, a novel B cell stimulatory factor: Unresponsiveness of X-chromosome-linked immunodeficiency B cells. J Exp Med 172, 1625-31 (1990).

19. Y. Hitoshi, E. Sonoda,Y. Kikuchi, S. Yonehara, H. Nakauchi, & K. Takatsu: IL-5 receptor positive B cells, but not eosinophils, are functionally and numerically influenced in mice carrying the X-linked immune defect. Int Immunol 5, 1183-90 (1993).

20. J. Hasbold & G. G. B. Klaus: B cells from CBA/N mice do not proliferate following ligation of CD40. Eur J Immunol 24, 152-7 (1994).

21. L. Santos-Argumedo, F. E. Lund, A. W. Heath, N. Solvason, W. W. Wu, J. C. Grimaldi, R. M. E. Parkhouse & M. Howard: CD38 unresponsiveness of xid B cells implicates Bruton's tyrosine kinase (btk) as a regulator of CD38 induced signal transduction. Int Immunol 7, 163-70 (1995).

22. P. Sideras, S. M¨ller, H. Shiels, H. Jin, W. N. Khan, L. Nilsson, E. Parkinson, J. D. Thomas, L. Brand‚n, I. Larsson, W. E. Paul, F. S. Rosen, F. W. Alt, D. Vetrie, C. I. E. Smith & K. G. Xanthopoulos: Genomic organization of mouse and human Bruton's agammaglobulinemia tyrosine kinase (Btk) loci. J Immunol 153, 5607-17 (1994).

23. K. Sato, H. Mano, T. Ariyama, J. Inazawa, Y. Yazaki & H. Hirai: Molecular cloning and analysis of the human Tec protein-tyrosine kinase. Leukemia 8, 1663-72 (1994).

24. H. Mano, K. Mano, B. Tang, M. Koehler, T. Yi, D. J. Gilbert, N. A. Jenkins, N. G. Copeland, & J. N. Ihle: Expression of a novel form of Tec kinase in hematopoietic cells and mapping of the gene to chromosome 5 near Kit. Oncogene 8, 417-24 (1993).

25. N. Tanaka, H. Asao, K. Ohtani, M. Nakamura & K. Sugamura: A novel human tyrosine kinase gene inducible in T cells by interleukin 2. FEBS Lett 324, 1-5 (1993).

26. J. D. Siliciano, T. A. Morrow & S. V. Desiderio: itk, a T cell-specific tyrosine kinase gene inducible by interleukin 2. Proc Natl Acad Sci USA 89, 11194-8 (1992).

27. R. J. Gregory, K. L. Kammermeyer, W. S. Vincent & S. G. Wadsworth: Primary sequence and developmental expression of a novel Drosophila melanogaster src gene. Mol Cell Biol 7, 2119-27 (1987).

28. M. Vihinen, M. D. Cooper, G. de Saint Basile, A. Fischer, R. A. Good, R. W. Hendriks, C. Kinnon, S.-P. Kwan, G. W. Litman, L. D. Notarangelo, H. D. Ochs, F. S. Rosen, D. Vetrie, A. D. B. Webster, B. J. M. Zegers & C. I. E. Smith: BTKbase: a database of XLA-causing mutations. Immunol Today 16, 460-5 (1995).

29. M. Vihinen, T. Iwata, C. Kinnon, S.-P. Kwan, H. D. Ochs, I. Vorechovský & C. I. E. Smith: BTKbase, mutation database for X-linked agammaglobulinemia (XLA). Nucleic Acids Res 24, 160-165 (1996).

30. M. Vihinen, R. A. Brooimans, S.-P. Kwan, H. Lehväslaiho, G. W. Litman, I. Resnick, H. D. Ochs, J. H. Schwaber, I. Vorechovský & C. I. E. Smith: BTKbase: XLA-mutation registry. Immunol Today 17, 502-506 (1996).

31. M. Vihinen, B. H. Belohradsky, R. N. Haire, E. Holinski-Feder, S.-P. Kwan, I. Lappalainen, H. Lehväslaiho, T. Lester, A. Meindl, H. D. Ochs, J. Ollila, I. Vorechovský, M. Weiss & C. I. E. Smith: BTKbase, mutation database for X-linked agammaglobulinemia (XLA). Nucleic Acids Res (in press).

32. M. Vihinen & C. I. E. Smith: Structural aspects of signal transduction in B-cells. Crit Rev Immunol 16, 251-75 (1996).

33. P. T. Mattsson, M. Vihinen & C. I. E. Smith: X-linked agammaglobulinemia (XLA): a genetic tyrosine kinase disease. BioEssays 18, 825-34 (1996).

34. Y. Aoki, K. J. Isselbacher & S. Pillai: Bruton tyrosine kinase is tyrosine phosphorylated and activated in pre-B lymphocytes and receptor-ligated B cells. Proc Natl Acad Sci USA 91, 10606-9 (1994).

35. M. de Weers, G. S. Brouns, S. Hinshelwood, C. Kinnon, R. K. B. Schuurman, R. W. Hendriks & J. Borst: B-cell antigen receptor stimulation activates the human Bruton's tyrosine kinase, which is deficient in X-linked agammaglobulinemia. J Biol Chem 269, 23857-60 (1994).

36. S. J. Saouf, S. Mahajan, R. B. Rowley, S. A. Kut, J. Fargnoli, A. L. Burkhardt, S. Tsukada, O. N. Witte & J. B. Bolen: Temporal differences in the activation of three classes of non-transmembrane protein tyrosine kinases following B-cell antigen receptor surface engagement. Proc Natl Acad Sci USA 91, 9524-8 (1994).

37. S. Mahajan, J. Fargnoli, A. L. Burkhardt, S. A. Kut, S. J. Saouf & J. B. Bolen: Src family protein tyrosine kinases induce autoactivation of Bruton's tyrosine kinase. Mol Cell Biol 15, 5304-11 (1995).

38. D. J. Rawlings, A. M. Scharenberg, H. Park, M. I. Wahl, S. Lin, R. M. Kato, A.-M. Fluckiger, O. N. Witte & J.-P. Kinet: Activation of the BTK by a phosphorylation mechanism initiated by SRC family kinases. Science 271, 822-5 (1996).

39. H. Park, M. I. Wahl, D. E. H. Afar, C. W. Turck, D. J. Rawlings, C. Tam, A. M. Scharenberg, J.-P. Kinet & O. N. Witte: Regulation of Btk function by a major autophosphorylation site within the SH3 domain. Immunity 4, 515-25 (1996).

40. D. E. H. Afar, H. Park, B. W. Howell, D. J. Rawlings, J. Cooper & O. N. Witte: Regulation of Btk by Src family tyrosine kinases. Mol Cell Biol 16, 3465-71 (1996).

41. C. Cheng, Z.-S. Ye & D. Baltimore: Binding of Bruton's tyrosine kinase to Fyn, Lyn, or Hck through a Src homology 3 domain-mediated interaction. Proc Natl Acad Sci USA 91, 8152-5 (1994).

42. K. Alexandropoulos, G. Cheng & D. Baltimore: Proline-rich sequences that bind to Src homology 3 domains with individual specificities. Proc Natl Acad Sci USA 92, 3110-14 (1995).

43. W. Yang, S. N. Malek & S. Desiderio: An SH3-binding site conserved in Bruton's tyrosine kinase and related tyrosine kinases mediates specific protein interactions in vitro and in vivo. J Biol Chem 270, 20832-40 (1995).

44. Y. Kawakami, L. Yao, T. Miura, S. Tsukada, O. N. Witte & T. Kawakami: Tyrosine phosphorylation and activation of Bruton tyrosine kinase upon FcepsilonRI cross-linking. Mol Cell Biol 14, 5108-13 (1994).

45. M. D. Goldstein, M. A. Debenedette, D. Hollenbaugh & T. H. Watts: Induction of costimulatory molecules B7-1 and B7-2 in murine B cells, The CBA/N mouse reveals a role for Bruton's tyrosine kinase in CD40-mediated B7 induction. Mol Immunol 33, 541-552 (1996).

46. J. S. Anderson, M. Teutsch, Z. Dong & H. H. Wortis: An essential role for tyrosine kinase in the regulation of Bruton's B-cell apoptosis. Proc Natl Acad Sci USA 93, 10966-71 (1996).

47. S. Sato, T. Katagiri, S. Takaki, Y. Kikuchi, Y. Hitoshi, S. Yonehara, S. Tsukada, D. Kitamura, T. Watanabe, O. Witte & K. Takatsu: IL-5 receptor-mediated tyrosine phosphorylation of SH2/SH3-containing proteins and activation of Bruton's tyrosine and Janus 2 kinases. J Exp Med 180, 2101-11 (1994).

48. T. Matsuda, M. Takahashi-Tezuka, T. Fukada, Y. Okuyama, Y. Fujitani, S. Tsukada, H. Mano, H. Hirai, O. N. Witte & T. Hirano: Association and activation of Btk and Tec tyrosine kinases by gp130, a signal transducer of the interleukin-6 family of cytokines. Blood 85, 627-33 (1995).

49. L. Yao, Y. Kawakami & T. Kawakami: The pleckstrin homology domain of Bruton tyrosine kinase interacts with protein kinase C. Proc Natl Acad Sci USA 91, 9175-9 (1994).

50. S. A. Langhans-Rajasekaran, Y. Wan & X.-Y. Huang: Activation of Tsk and Btk tyrosine kinases by G protein bg subunits. Proc Natl Acad Sci USA 92, 8601-5 (1996).

51. T. Li, S. Tsukada, A. Satterthwaite, M. H. Havlik, H. Park, K. Takatsu & O. N. Witte: Activation of Bruton's tyrosine kinase (BTK) by a point mutation in its pleckstrin homology (PH) domain. Immunity 2, 451-60 (1995).

52. M. Takata & T. Kurosaki. A role for Bruton's tyrosine kinase in B cell antigen receptor-mediated activation of phospholipase C- 2. J Exp Med 184, 31-40 (1996).

53. F. M. Uckun, K. G. Waddick, S. Mahajan, X. Jun, M. Takata, J. Bolen & T. Kurosaki: BTK as a mediator of radiation-induced apoptosis in DT-40 lymphoma B cells. Science 273, 1096-1100 (1996).

54. G. O. C. Cory, R. C. Lovering, S. Hinshelwood, L. MacCarthy-Morrogh, R. J. Levinski & C. Kinnon: The protein product of the c-cbl protooncogene is phosphorylated after B cell receptor stimulation and binds the SH3 domain of Bruton's tyrosine kinase. J Exp Med 182, 611-5 (1995).

55. A. Ridderstad, G. J. V. Nossal & D. M. Tarlinton: The xid diminishes memory B cell generation but does not affect somatic hypermutation and selection. J Immunol 157, 3357-65 (1996).

56. J. E. Harlan, P. J. Hajduk, H. S. Yoon & S. W. Fesik: Pleckstrin homology domains bind to phosphatidylinositol-4,5-bisphosphate. Nature 371, 168-70 (1996).

57. J. E. Harlan, H. S. Yoon, P. J. Hajduk & S. W. Fesik: Structural characterization of the interaction between a pleckstrin homology domain and phosphatidylinositol 4,5-bisphosphate. Biochemistry 34, 9859-64 (1995).

58. D. Fushman, S. Cahill, M. A. Lemmon, J. Schlessinger & D. Cowburn: Solution structure of pleckstrin homology domain of dynamin by heteronuclear NMR spectroscopy. Proc Natl Acad Sci USA 92, 816-20 (1995).

59. M. Hyvönen, M. J. Macias, M. Nilges, H. Oschkinat, M. Saraste & M. Wilmanns: Structure of the binding site for inositol phosphates in a PH domain. EMBO J 14, 4676-85 (1995).

60. K. M. Ferguson, M. A. Lemmon, J. Schlessinger & P. B. Sigler: Structure of the high affinity complex of inositol trisphosphate with a phospholipase C pleckstrin homology domain. Cell 83, 1037-46 (1995).

61. P Garcia, R. Gupta, S. Shah, A. J. Morris, S. A. Rudge, S. Scarlata, V. Petrova, S. McLaughlin & M. J. Rebecchi: The pleckstrin homology domain of phosopholipase C-_delta1 binds with high affinity to phophatidylinositol 4,5-bisphosphate in bilayer membranes. Biochem 34, 16228-34 (1995).

62. H. F. Paterson, J. W. Savopoulos, O. Perisic, R. Cheung, M. V. Ellis, R. L. Williams & M. Katan: Phospholipase C-_delta1 requires a pleckstrin homology domain for interaction with the plasma membrane. Biochem J 312, 661-6 (1995).

63. J. Zheng, S. M. Cahill, M. A. Lemmon, D. Fushman, J. Schlessinger & D. Cowburn: Identification of the binding site for acidic phospholipids on the PH domain of dynamin: implications for stimulation of GTPase activity. J Mol Biol 255, 14-21 (1996).

64. M. A. Lemmon, K. M. Ferguson, R. O'Brien, P. B. Sigler & J. Schlessinger: Specific and high-affinity binding of inositol phosphates to an isolated pleckstrin homology domain. Proc Natl Acad Sci USA 92, 10472-6 (1995).

65. H. Takeuchi, T. Kanematsu, Y. Misuni, H. B. Yaakob, H. Yagisawa, Y. Ikehara, Y. Watanabe, Z. Tan, S. B. Shears & M. Hirata: Localization of a high-affinity inositol 1,4,5-trisphosphate/inositol 1,4,5,6-tetrakisphosphate binding domain to the plecksrin homology module of a new 130 kDa protein: characterization of the determinants of structural specificity. Biochem J 318, 561-8 (1996).

66. D.-S. Wang, R. Miller, R. Shaw & G. Shaw: The pleckstrin homology domain of human bISII spectrin is targeted to the plasma membrane in vivo. Biochem Biophys Res Commun 225, 420-6 (1996).

67. Y. Zheng, D. Zangrilli, R. A. Cerione, A. Eva: The pleckstrin homology domain mediates transformation by oncogenic Dbl through specific intracellular targeting. J Biol Chem 271, 19017-20 (1996).

68. M. A. Beaven & H. Metzger: Signal transduction by Fc receptors: the Fc RI case. Immunol Today 14, 222-6 (1993).

69. Q. Zhu, M. Zhang, D. J. Rawlings, M. Vihinen, T. Hagemann, D. C. Saffran, S.-P. Kwan, L. Nilsson, C. I. E. Smith, O. N. Witte, S.-H. Chen & H. D. Ochs: Deletion within the Src homology domain 3 of Bruton's tyrosine kinase resulting in X-linked agammaglobulinemia (XLA). J Exp Med 180, 461-70 (1994).

70. M. Vihinen, D. Vetrie, H. S. Maniar, H. D. Ochs, Q. Zhu, I. Vorechovský, A. D. B. Webster, L. D. Notarangelo, L. Nilsson, J. M. Sowadski & C. I. E. Smith: Structural basis for chromosome X-linked agammaglobulinemia: A tyrosine kinase disease. Proc Natl Acad Sci USA 91, 12803-7 (1994).

71. M. Vihinen, L. Nilsson & C. I. E. Smith: Structural basis of SH2 domain mutations in X-linked agammaglobulinemia. Biochem Biophys Res Commun 205, 1270-7 (1994).

72. M. Vihinen, M. J. J. M. Zvelebil, Q. Zhu, R. A. Brooimans, H. D. Ochs, B. J. M. Zegers, L. Nilsson, M. D. Waterfield & C. I. E. Smith: Structural basis for pleckstrin homology domain mutations in X-linked agammaglobulinemia. Biochem 34, 1475-81 (1995).

73. R. J. Haslam, H. B. Koide & B. A. Hemmings: Pleckstrin domain homology. Nature 363, 309-10 (1993).

74. B. J. Mayer, R. Ren, K. L. Clark & D. Baltimore: A putative modular domain present in diverse signaling proteins. Cell 73, 629-30 (1993).

75. G. Shaw: Identification of novel pleckstrin homology (PH) domains provides a hypothesis for PH domain function. Biochem Biophys Res Commun 195, 1145-51 (1993).

76. A. Musacchio, T. Gibson, P. Rice, J. Thompson & M. Saraste: The PH domain: a common piece in the structural patchwork of signalling proteins. Trends Biochem Sci 18, 343-8 (1993).

77. T. J. Gibson, M. Hyvönen, A. Musacchio, M. Saraste & E. Birney: PH domain, the first anniversary. Trends Biochem Sci 19, 349-53 (1994).

78. M. Saraste & M. Hyvönen: Pleckstrin homology domains: a fact file. Curr Opin Struct Biol 5, 403-408 (1995).

79. G. Shaw: The pleckstrin homology domain: an intriguing multifunctional protein module. BioEssays 18, 35-46 (1996).

80. A. K. Downing, P. C. Driscoll, I. Gout, K. Salim, M. J. Zvelebil & M. D. Waterfield: Three-dimensional solution structure of the pleckstrin homology domain from dynamin. Curr Biol 4, 884-91 (1994).

81. D. Timm, K. Salim, I. Gout, L. Guruprasad, M. Waterfield & T. Blundell: Crystal structure of the pleckstrin homology domain from dynamin. Nature Struct Biol 1, 782-788 (1994).

82. K. Salim, M. J. Bottomley, E. Querfurth, M. J. Zvelebil, I. Gout, R. Scaife, R. L. Margolis, R. Gigg, C. I. E. Smith, P. C. Driscoll, M. D. Waterfield & G. Panayotou: Distinct specificity in the recognition of phosphoinositides by the pleckstrin homology domains of dynamin and Bruton's tyrosine kinase. EMBO J 15, 6241-50 (1996).

83. J. D. Thomas, P. Sideras, C. I. E. Smith, I. Vorechovský, V. Chapman & W. E. Paul: Colocalization of X-linked agammaglobulinemia and X-linked immunodeficiency genes. Science 261, 355-8 (1993).

84. D. J. Rawlings, D. C. Saffran, S. Tsukada, D. A. Largaespada, J. C. Grimaldi, L. Cohen, R. N. Mohr, J. F. Bazan, M. Howard, N. G. Copeland, N. A. Jenkins & O. N. Witte: Mutation of unique region of Bruton's tyrosine kinase in immunodeficient XID mice. Science 261, 358-61 (1993).

85. K. Touhara, J. Inglese, J. A. Pitcher, G. Shaw & R. J. Lefkowitz: Binding of G protein ßgamma-subunits to pleckstrin homology domains. J Biol Chem 269, 10217-20 (1994).

86. D. Mahadevan, N. Thanki, J. Singh, P. McPhie, D. Zangrilli, L.-M. Wang, C. Guerrero, H. LeVine, C. Humblet, J. Saldanha, J. S. Gutkind & T. Najmabadi-Haske: Structural studies on the PH domains of Dbl, Sos1, IRS-1 & ßARK1 and their differential binding to G subunits. Biochem 34, 9111-7 (1995).

87. C. I. E. Smith, K. B. Islam, I. Vorechovský, O. Olerup, E. Wallin, H. Rabbani, B. Baskin & L. Hammarström: X-linked agammaglobulinemia and other immunoglobulin deficiencies. Immunol Rev 138, 159-83 (1994).

88. M. Vihinen, L. Nilsson & C. I. E. Smith: Tec homology (TH) adjacent to the PH domain. FEBS Lett 350, 263-5 (1994).

89. H. Mano, K. Sato, Y. Yazaki & H. Hirai: Tec protein-tyrosine kinase directly associates with Lyn protein-tyrosine kinase through its N-terminal unique domain. Oncogene 9, 3205-11 (1994).

90. M. Machide, H. Mano & K. Todokoro: Interleukin 3 and erythropoietin induce association of Vav with Tec kinase through Tec homology domain. Oncogene 11, 619-25 (1995).

91. M. E. M. Noble, A. Musacchio, M. Saraste, S. A. Courtneidge & R. K. Wierenga: Crystal structure of the SH3 domain in human Fyn; comparison of the three-dimensional structures of SH3 domains in tyrosine kinases and spectrin. EMBO J 12, 2617-24 (1993).

92. A. Musacchio, M. Saraste & M. Wilmanns: High-resolution crystal structures of tyrosine kinase SH3 domains complexed with proline-rich peptides. Nature Struct Biol 1, 546-51 (1994).

93. C. J. Morton, D. J. R. Pugh, E. L. J. Brown, J. D. Kahmann, D. A. C. Renzoni & I. D. Campbell: Solution structure and peptide binding of the SH3 domain from human Fyn. Structure 4, 705-14 (1996).

94. S. Feng, J. K. Chen, H. Yu, J. A. Simon & S. L. Schreiber: Two binding orientations for peptides to the Src SH3 domain: Development of a general model for SH3-ligand interactions. Science 266, 1241-1247 (1994).

95. R. J. Rickles, M. C. Botfield, Z. Weng, J. A. Taylor, O. M. Green, J. S. Bruge & M. J. Zoller: Identification of Src, Fyn, Lyn, PI3K and Abl SH3 domain ligands using phage display libraries. EMBO J 13, 5598-5604 (1994).

96. A. B. Sparks, J. E. Rider, N. G. Hoffman, D. M. Fowlkes, L. A. Quilliam & B. K. Kay: Distinct ligand preferences of Src homology 3 domains from Src, Yes, Abl, Cortactin, p53bp2, PLC , Crk, and Grb2. Proc Natl Acad Sci USA 93, 1540-4 (1996).

97. Z. Weng, R. J. Rickles, S. Feng, S. Richard, A. S. Shaw, S. L. Schreiber & J. S. Brugge: Structure-function analysis of SH3 domains: SH3 binding specificity altered by amino acid substitutions. Mol Cell Biol 15, 5627-34 (1995).

98. B. S. Knudsen, J. Zheng, S. M. Feller, J. P. Mayer, S. K. Burrell, D. Cowburn & H. Hanafusa: Affinity and specificity requirements for the first Src homology 3 domain of the Crk proteins. EMBO J 14, 2191-8 (1995).

99. C.-H. Lee, B. Leung, M. A. Lemmon, J. Zheng, D. Cowburn, J. Kuriyan & K. Saksela: A single amino acid in the SH3 domain of Hck determines its high affinity and specificity in binding to HIV-1 Nef protein. EMBO J 14, 5006-15 (1995).

100. H. B. Gaspar, L. A. D. Bradley, F. Katz, R. C. Lovering, C. M. Roifman, G. Morgan, R. J. Levinsky & C. Kinnon: Mutation analysis in Bruton's tyrosine kinase, the X-linked agammaglobulinaemia gene, including identification of an insertional hotspot. Hum Mol Genet 4, 755-7 (1995).

101. M. J. Eck, S. K. Atwell, S. E. Shoelson & S. C. Harrison: Structure of the regulatory domains of the Src-family tyrosine kinase Lck. Nature 368, 764-9 (1994).

102. Z. Songyang, S. E. Shoelson, M. Chaudhuri, G. Gish, T. Pawson, W. G. Haser, F. King, T. Roberts, S. Ratnofsky, R. J. Lechleider, B. G. Neel, R. B. Birge, J. E. Fajardo, M. M. Chou, H. Hanafusa, B. Schaffhausen & L. C. Cantley: SH2 domains recognize specific phosphopeptide sequences. Cell 72, 767-78 (1993).

103. Z. Songyang, S. E. Shoelson, J. McGlade, P. Olivier, T. Pawson, X. R. Bustelo, M. Barbacid, H. Sabe, H. Hanafusa, T. Yi, R. Ren, D. Baltimore, S. Ratnofsky, R. A. Feldman & L. C. Cantley: Specific motifs recognized by the SH2 domains of Csk, 3BP2, fps/fes, GRB-2, HCP, SHC, Syk, and Vav. Mol Cell Biol 14, 2777-85 (1994).

104. D. R. Knighton, J. Zheng, L. F. Ten Eyck, V. A. Ashford, N.-h. Xuong, S. S. Taylor & J. M. Sowadski: Crystal structure of the catalytic subunit of cyclic adenosine monophosphate-dependent protein kinase. Science 253, 407-14 (1991).

105. D. R. Knighton, J. Zheng, L. F. Ten Eyck, N.-h. Xuong, S. S. Taylor & J. M. Sowadski: Structure of a peptide inhibitor bound to the catalytic subunit of cyclic adenosine monophosphate-dependent protein kinase. Science 253, 414-420 (1991).

106. D. R. Knighton, S. M. Bell, J. Zheng, L. F. Ten Eyck, N.-H. Xuong, S. S. Taylor & J. M. Sowadski: 2.0 ¸ refined crystal structure of the catalytic subunit of cAMP-dependent protein kinase complexed with a peptide inhibitor and detergent. Acta Cryst D49, 357-61 (1993).

107. J. Zheng, E. A. Trafny, D. R. Knighton, N.-H. Xuong, S. S. Taylor, L. F. Ten Eyck & J. M. Sowadski: 2.2 ¸ refined crystal structure of the catalytic subunit of cAMP-dependent protein kinase complexed with MnATP and peptide inhibitor. Acta Cryst D49, 362-5 (1993).

108. D. Bossemeyer, R. A. Engh, V. Kinzel, H. Ponstingl & R. Huber: Phosphotransferase and substrate binding mechanism of the cAMP-dependent protein kinase catalytic subunit from porcine heart as deduced from the 2.0 ¸ structure of the complex with Mn2+ adenylyl imidodiphosphate and inhibitor peptide PKI(5-24). EMBO J 12, 849-859 (1993).

109. S. K. Hanks: Eukaryotic protein kinases. Curr Opin Struct Biol 1, 369-83 (1991).

110. J. Zheng, D. R. Knighton, L. F. Ten Eyck, R. Karlsson, N.-h. Xuong, S. S. Taylor & J. M. Sowadski: Crystal structure of the catalytic subunit of cAMP-dependent protein kinase complexed with MgATP and peptide inhibitor. Biochem 32, 2154-61 (1993).

111. Madhusudan, E. A. Trafny, N.-h. Xuong, J. A. Adams, L. F. Ten Eyck, S. S. Taylor & J. M. Sowadski: cAMP-dependent protein kinase: Crystallographic insights into substrate recognition and phosphotransfer. Prot Sci 3, 176-87 (1994).

112. S. Cox, E. Radzio-Andzelm & S. S. Taylor: Domain movements in protein kinases. Curr Opin Struct Biol 4, 893-901 (1994).

113. M.-f. Ho, H. N. Bramson, D. E. Hansen, J. R. Knowles & E. T. Kaiser: Stereochemical course of the phospho group transfer catalyzed by cAMP-dependent protein kinase. J Amer Chem Soc 110, 2680-1 (1988).

114. I. Vorechovský, M. Vihinen, G. de Saint Basile, S. Honsová, L. Hammarstöm, S. Möller, L. Nilsson, A. Fischer & C. I. E. Smith: DNA-based mutation analysis of Bruton's tyrosine kinase gene in patients with X-linked agammaglobulinemia. Hum Mol Genet 4, 51-8 (1995).

115. H. Jin, A. D. B. Webster, M. Vihinen, P. Sideras, I. Vorechovský, L. Hammarström, E. Bernatowska-Matuszkiewicz, C. I. E. Smith, M. Bobrow & D. Vetrie: Identification of Btk mutations in 20 unrelated patients with X-linked agammaglobulinemia (XLA). Hum Mol Genet 4, 693-700 (1995).

116. H. S. Maniar, M. Vihinen, A. D. B. Webster, L. Nilsson & C. I. E. Smith: Structural basis for X-linked agammaglobulinemia (XLA). Mutations at interacting Btk residues R562, W563 and A582. Clin Immunol Immunopathol 76, S198-S202 (1995).